| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.02 | 0.9 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |